I'm Samantha Holway, Head of Investor Relations at Herbalife, and I'm joined by John DeSimone, our Chief Financial Officer and incoming interim CEO. Scott Schaefer, our Senior Vice President of Finance and Transformation and incoming CFO. Before we begin, I would like to direct you to the cautionary statement regarding forward-looking statements that is available under the Investor Relations section of Herbalife's website. This fireside chat will include a discussion of some of the more important factors that could cause results to differ from those expressed in any forward-looking statement within the meaning of the Private Securities Litigation Reform Act of 1995. As is customary, the content of today's presentation will be governed by this language. In addition, during today's presentation, we may discuss certain non-GAAP financial measures. These non-GAAP financial measures exclude certain unusual or non-recurring items that management believes impact the comparability of the periods referenced.
Please refer to our Investor Relations website for additional information regarding these non-GAAP financial measures and the reconciliations to the most directly comparable GAAP measure. With that, I'll hand it back over to Hale.
Thanks, Sam. John, the company comes into the conference with four quarters of top-line growth, stated path to bring leverage into the 1x range by 2028. The buyback that you announced yesterday. The early stages of a push into personalized data-enabled nutrition. You've also had some recent management changes. Maybe walk us through what the CEO transition announcement and what interim means in your title.
Yeah, sure. For those who are unfamiliar with what's happened in the last few years, about three years ago, we had one of our top distributors, our second-most successful distributor in the 46-year history of the company, join as an employee. We were going through some post-pandemic challenges, as was our industry, and he was bringing a distributor perspective in. He came in as Chief Strategy Officer, then President, and then CEO. He brought that unique angle that helped us create a vision and a strategy for the longer term. We've announced that he's going back to running his distributorship at the end of October. Incredibly grateful for the insight he brought in, for the new vision and strategy. Company's in a much better place today than it was coming out of the pandemic. Nine of our last 11 quarters, we've had local currency net sales growth.
The last four quarters, we had reported net sales growth. We have had volume growth in the last four quarters. Our balance sheet has been strengthened. Three years ago, our leverage ratio was 3.9, gross leverage ratio. Now it is 2.7 or 2.8, in that range. We have got a new debt deal, saving a lot of money of interest. We are in a much better spot right now for Stephan now to return. Stephan is the person we are talking about, who is our current CEO, to return back to his distributorship. At the same time, just prior to this, we announced a CFO transition. When I came back to the CFO. For my background, I was CFO from 2010 to the middle of 2018. Had a couple other roles with the company after that. Semi-retired, came back in early 2024.
One of my objectives when I came back, in addition to strengthening the balance sheet, was to hire a successor. About a year ago, Scott came in, and we are very comfortable that he is the right person. We announced my retirement at the end of the year, and Scott was going to jump in on January 1st. Those two transitions were actually disconnected. I think it was fortuitous because with Stephan going back to his distributorship, I have already had a replacement. For me, I am stepping in as an interim CEO. I have been at the company for 18 years. I know the company very well. I am no longer retiring on December 31st. I will be interim for as long as it takes to find the right candidate. I think that is an important takeaway for the audience. I understand the business.
We have got an incredibly strong executive team. I will be here for as long as it takes, and I will be here for whatever transition a new CEO, whatever help they need. We are doing this in a position of financial strength, right? This is not a traditional CEO transition. In fact, we are not even losing Stephan, who is our current CEO. He is our number two distributor. In his organization, he has about half a billion in revenue. He has not been able to run that distributorship as CEO. It has to go in a trust. Now he gets to go back and run that distributorship, and that is one of the reasons for such a quick transition. That is just some context around the situation and both Stephan's situation, my situation, and Scott's situation.
Stephan's transition, does that change the personalized nutrition push that the company is—
No. Again, for some context, our core business is doing very well. Like I said, last four quarters, we've had volume growth, strong net sales growth. There is a vision, and the foundation of that vision is we've got 6 million members. Members are somebody who's a distributor or a preferred customer that can buy directly from us. In addition, we have millions of additional customers. When we talk about Nutrition Clubs, which we'll talk about at some point today, these are consumers coming into a fixed location to buy basically a single serve of our product. in the U.S. alone, we have 4 million customers that are not distributors. In just the U.S. alone. We have reach into tens of millions of customers, if you extrapolate out the U.S. customer base. We believe the next wave in health and wellness nutrition is personalization.
Herbalife's been grounded in personalization since it started. Our distributors ultimately create a personalized program for their customers to be successful, but it's more of a curated program. The vision going forward is more of a formulated, personalized product. Taking the data consumers have available to them today is exponentially greater than the data they've had available just a decade or two decades ago. It used to be just a scale, or you measure how many bench presses you could do, or there was measurements, but it was minimal. The amount of data a consumer has today with their ability to get blood work. I mean, blood work is a commodity. Anybody can go get their own biomarkers. What do you do with that data?
We want to own the space where we can take that data, whether it's biomarker data or just survey data, where you answer a series of questions, and we can create a product specifically for your needs. That is an important part of our strategy, and that's not going to change. It's a spectrum. We're personalized today on a curated standpoint. We want to go to personally formulated. We think we have the foundation for it because we've got the millions of customers. We'll have the ability to get the data. There's going to be a journey to get there on that spectrum, but that's an important part of our future.
My son's playing football, and he sent me his WHOOP score last night and then told me I needed to get off my butt and—
Yeah, right. WHOOP or Oura Ring, I mean, the amount of data is a bit. What do you do with the data? That's the confusing part for consumers. We want to be the experts that say, "Take that data. Here's what you do to improve it and reach your goals".
Apparently making fun of your father who's not playing high school sports anymore. Any changes to the capital allocation policy that you guys have outlined or the way you think —
Well, a little bit. For those who are unfamiliar, again, I feel like I want to give background for those who are unfamiliar with Herbalife. We generate a lot of cash. Perspective, over the last four quarters, our free cash flow yield is 23%. We've always generated cash. The reason we have debt is because we've done a lot of buybacks over the years. We've bought back $6.5 billion of stock since I joined the company. A lot of that was strategic. Some of it was, we had a board member who was a big investor and ultimately bought that position out. That was not strategic, but the rest of it was strategic. Coming out of the pandemic, when business changed, our balance sheet didn't look so strong anymore, and so we focused that cash on paying down debt, which we've done a lot of in the last three years.
Over $800 million, I believe, in the last three years. Our goal was to pay another $600 million down by the end of 2028. But where our stock is right now, and our multiple's incredibly low, incredibly undervalued for a company that's growing, that generates cash. We announced yesterday a $250 million three-year buyback program. We're going to work in the buyback along with paying down debt. That does mean maybe the 2028 goal of paying down another $600 million might get pushed out a little to 2029, which is fine because the maturity of the debt deals we just did doesn't happen until the early 2030s. We'll still hit that goal. Yeah, I think our priorities have changed. You'll start seeing a buyback program that gets implemented.
We announced it in advance of this conference, so we could talk about it in our meetings with our investors. It's not likely to be implemented until next quarter because our blackout period by policy starts tomorrow. There really isn't enough time to execute something in Q3, but at least we can talk about it, investors know it's coming, and we can start executing it, beginning with our earnings announcement. That'll be early November.
So at the risk of making this a little weird for Scott, one of the things that got a lot better when you came back to the company, John, was the ability to hit guidance, project, have some financial rigor, and hold yourself accountable for the goals that you had out there. Maybe talk about your confidence of how that's institutionalized in the way you do things now, so that when you depart at some point in the future, Scott can carry that forward.
Yeah, look, there was a time, like when I was not in the company, where we, again, it was challenging times coming out of the pandemic, and we pulled guidance. A couple of things. We will always guide. That's my commitment. I think Scott agrees with that.
Agreed.
We guide with the best information we have possible, but there is a lot of rigor and a lot of different models we use to guide. Hundreds of models, ultimately, that we use to find what we think is the best model to use for guidance. Over the last two years, I think in the net— last three years. Since I came back, we've missed net sales once, but haven't missed EBITDA. We've exceeded guidance. I do think it's been institutionalized, knock on wood. Every time you guide, at some point, you're going to miss. We all have to deal with that. But I think we have a lot of rigor in the process. Scott, who's the next CFO, his background, he was with Zappos for 18 years, I believe.
16.
16 years. From when it was its standalone company to when it was a division of Amazon. He rose up to not just the CFO position, but the CEO position for three years. Working for Amazon, I think financial discipline, operating rigor, and accountability is core to that environment, so I think it's in Scott's DNA too.
Scott, I was hoping for better shoes from you, to be honest, but—
Oh.
I do wonder how you got from Zappos to Herbalife, because presumably you spent a lot of time at Zappos, and Herbalife may not have been on your operating radar. So maybe talk about what attracted you to the company or how you ended up there.
Yeah. So after exiting Zappos, decided we want to take a year off, and halfway through that window, started to search for what's next. I was actually about to join another firm with a contract opportunity back in the shoe game, as a CFO, COO. Right before I signed the contract, one of the recruiters I was working with reached out and surfaced this opportunity with Herbalife. I've always been into the health and wellness, kind of journey over time. I'm familiar with the company, but wasn't deeply familiar. So I was like, "Yeah, this seems like a really interesting opportunity." The profile looked great, and I met with John first, and then I met with the CEO, Stephan. What was striking that made me really pause and really become extremely interested was how it presented both purpose and opportunity.
Zappos was a company that was purpose first, values first. When you're creating value for people, profit follows and cash follows. We lived our values every single day, and the culture and the company and really the purpose of helping small business owners create something unique for themselves, it struck me. I thought it was something that I did want to pursue a little bit further. On the opportunity side, the company had come through a kind of corrective period coming out of COVID and was on stable footing. Learned a lot from John in terms of the margin expansion and the goal that we have set forward on debt paydown, and it seemed like it was just a really great time for me to jump, and the rest is history.
I've been with the company now about 10 months, and extremely grateful to be part of it. It feels very much like home.
What are the two or three metrics that you're going to focus on as CFO that you want to hold the company accountable for, or your team accountable for?
Yeah. When you think about first the financial and then the operational, I think on the financial side, clearly free cash flow. This is a great cash-generating business. As we focus on margin expansion being number two, our ability to drive top-line growth, margin expansion's only going to yield stronger free cash flow. This is not a capital-intensive business, so there's a lot of operating cash and free cash that we generate. Those are a couple where we're going to set some long-term targets for ourselves, and I think we can do really well. The operational one, the way we go to market is through our distributors, and they're kind of our first line of customers. Then, of course, they have their customers that they work with. Experience metrics matter. They are effectively operational metrics.
The couple that I really want to hold ourselves accountable is how can we create a great experience for our distributors? This is everything from inventory efficiency, making sure that we have product in stock so they can meet consumer demands, to things like click-to-deliver rates, right? Making sure that we can get the product to our distributors and our customers in an appropriate time to help them service their small business needs. Just a couple of those operational metrics, because those have a significant impact on the experience that they can create for their customers.
John, you've got a clock on your tenure here, maybe an hour, an extended time, but what do you want to finish before you leave?
I'll speak to it as a CFO position, not as the interim CEO, because there's things I want to do on both. Our historical margin rate, EBITDA margin, was north of 15%, right around 15%, between 15% and 16% for a long time. We went, dipped down really low to 11.3% coming out of COVID in 2023. We worked our way up to just over 13% last year. We want to see if we can get back to 15%. I think there's a little bit of aspirational goals there because of some. The more familiar you get with us, the more you'll understand this next comment. There's an India GST tax issue that's great for sales, but hurts margins a little, so it's creating a mix issue. Still hugely beneficial to us as a company, but it puts pressure on the margin number, but adds a lot of profit dollars.
We're working on a path, a roadmap to get our margins back up. Whether we get to 15% or maybe we get to 15% less the impact of GST, we want to have that clear roadmap out over the multiple years we need to get there. Scott's a big part of that, and I'd like to have that done before I leave.
We talked about this a little bit yesterday, but you have these new products that are coming that are different than the core. You have a distributor base that is a unique attribute of the company in the sense that they are not direct employees. Most of your cash is coming from the core nutrition products at the moment. How do you make sure that the distributors don't get distracted with the shiny new toys, or that things get levered in the right way, and that growth moves up into the right the way you want it to?
Yeah. Well, first of all, I think I am going to reframe it because I think I am not worried about distributors getting distracted from the next bright, shiny object.
Okay.
Right? Because they are going to do whatever makes them the most money. They are all independent entrepreneurs. They know what works. They have their business flows. They don't change easily. The real question is, how do we as a company not get distracted with the bright, shiny object so we are not working on things that don't add value? Our job is to help add value to the distributor. If we launch something, they are not going to be distracted. If it doesn't work for them, they just won't use it. Our job is to add value. That is what we believe we are doing with our initiatives, and we do that multiple ways, but one of the ways is a lot of interaction with our distributors. For example, with our new technology platform, Pro2col, it is an application. We are having, we call them labs.
Our distributors have different business flows. Those business flows have names. Nutrition Clubs is one of the names, but there is a lot of them. We bring in the top distributors that have those business flows in these labs to help us launch a product that they believe will help them. I am not worried about distraction. It is more the other way around, is making sure we put the energy and effort into things that actually add value, otherwise they won't use it.
Right. I guess the flip side of that is how do you move the needle on the distributor economic model so that they do adopt these, and it becomes profitable for them?
Yeah. There's two things that have to marry up. It has to be value for the consumer, and it has to help a distributor make money. Those are the two things our initiatives need to affect for it to be successful. Again, I'm not at all worried about that. I think what we're launching, with their interaction, will help drive value.
Scott, you came in after Herbalife One was kind of cleaned up by John, which is probably a nice thing for your stress levels. Maybe if you guys could both talk about where you are in the digital transformation, what you have left to do. Is that an ongoing sort of cost drag as you go forward?
We use the phrase Herbalife One. It was a large internal technology investment to kind of clean up a lot of the middleware and connect a lot of our systems together to be more efficient, both internally and for distributor facing, significant investment over a number of years. That project concluded about a year or so ago. Our digital transformation, it's not going to stop it. What we're doing, for the most part, is not heavily capital intensive. Our typical CapEx rate runs between 1%- 2% of sales. The couple of things that we have going right now, which I think no matter what, we're going to continue to invest in a good digital experience that is obviously internal for efficiency and external for helping derive growth for our distributors and for ourselves.
Where we are in the journey right now is if you look at the consumer facing side of it, our Pro2col investment. How can we better connect in customers and their data with distributors to help them create creative value and then also again, create better business opportunity for themselves? That is a journey that we are going to continue to be on, and that development cycle will continue.
I would say we are still early in that development cycle. That is not the only consumer facing or distributor facing technology that we have. I think there is still a lot more that we can continue to do to improve those experiences and possibly combine some of the applications and reduce some of the overall tech overhead. I think that is going to be part of that journey. The other side of it is we have some other internal projects that we are doing.
Our Oracle ERP is an on-prem system right now. We have a large project that is through 2028 and goes into 2029 in some of the later boundary systems to move to a cloud infrastructure. That project, again, this is the biggest year for the capital-intensive portion of it. We are going to get a lot of gains out of it for internal efficiencies because we cannot take advantage of a lot of the things like the AI native aspects of what cloud has to offer because we are on-prem server . With that, we are expecting actually some labor efficiencies down the road where we can apply AI automation for things like translation services for our contact center. That can help us do some consolidation efforts. We are always going to be on a journey of creating a great infrastructure that can help with efficiency internally and externally.
It is never going to be done the same way. I should not say never, but we do not anticipate it being done in the same way as with Herbalife One and the level of investment. But sticking within that 1%-2% range and trying to create incremental efficiencies for ourselves and growth opportunities for our distributors will always be our journey.
Do you think the distributors have the right AI tools now to help sell your products? Because you have a pretty wide slot, but it would seem like there would be either an internal or external AI interface that could accelerate it.
I completely agree. I would say we are still early in our journey. We have this internal group called Key Account Managers. It is actually one of the programs that Stephan helped create, and it is a group of folks that will go out and work with key distributor leaders and help them understand deeper about their business, surface with them insights, and hold them accountable to specific goals because they are independent. They are not employees, right? They are independent business owners. If coaching and how a distributor holds their consumer accountable, we kind of take that same philosophy and see, okay, great, how can we create metrics and hold these key accounts accountable too, if they want to be held in the same way?
We actually have created some AI tools internally that we are using to surface insights in a way where we have not been able to before, connecting into our Snowflake data lake, and then from there, surfacing these key insights that have been a strong driver for us. I think we are at the infancy Pro2col also, as part of its journey, is going to have some AI capabilities. Those surface next best action type activities for distributors. We are early, but it is an investment that we are continuing to make.
Sam, before you had your current role, you were working in the North America distributor base, and the North America base is pretty unique with this Nutrition Club model. Maybe you could spend 30 seconds explaining why it is unique and different than the rest of the world, but also how you move the Nutrition Clubs from selling sort of a single serve, effectively a shake, to some of these new initiatives that are more subscription based.
Yeah, sure.
I'm sorry. I just want to add a little bit more about Samantha's background because I think it adds more credibility to the answer. She's got a financial background, big four accounting firm, and she came into Herbalife through finance. But for the last couple of years, she moved to the front end of the business. She wasn't just working with distributors. She ran sales for North America. She's speaking from a position of authority here.
Thanks, John. Yeah, look, I'll really quickly describe a Nutrition Club. John sort of touched on it. We have Nutrition Clubs all over the world, but in North America, they really primarily are a single-serve . Think going into any coffee shop and getting a tea, in an Herbalife Nutrition Club, you're going in and you're getting a tea or a protein shake at an accessible price point. But they're not just that, and this is why they're poised really well to adopt the new initiatives. They have multiple methods, multiple different business flows happening within these brick-and-mortar walls. People come in for a daily workout, or they come in for a body transformation challenge. And every day, customers are looking for support on whatever health journey they might be on.
That doesn't just get solved by what you drink over the counter that the distributor may be serving you. It also needs to be solved by what you're taking at home, what you go home, whether it's your vitamins and minerals like a Bionic, or it's helping you along your journey when you're not inside the club, like a Pro2col application could support. And I think too, building off some of the digital transformation, the new capabilities that we've brought into market, we have new commerce platforms with subscription capabilities, and these only help upsell from the Nutrition Club standpoint.
It helps distributors who are really busy servicing customers over the counter, and they can just point to a QR Code and, "Hey, if you want this at home or you want to take a wellness assessment to get your personal one of 40 formulations in Bionic," then they have those digital capabilities that they need to scale beyond just what happens within the four walls of the club.
I probably should have started with this question, but the whiteboard vision, right? You guys have Pro2col, Bionic, Link BioSciences, Life I/O. Those are the four new ones. You've got the existing coaching business, which is kind of the core of the company. You have the nutrition products, and then you also have the sports products. So what's the ideal customer journey here? I get onboarded through a distributor. She or he gets me really excited. How do I get sold, like in the perfect world?
So it's our ability to personalize that journey is key. We're in 95 countries. We have 2 million distributors. The customer journey can be very different in Bogota than it can be in Barcelona than it can be in Boston.
A lot of Bs there.
A lot of B. I did that on purpose once I got it going, right? It's just, again, if you just want to picture a global footprint with millions of customers, and how do you service those customers? Each customer has a unique journey. A distributor's job is to create the journey that's unique to you. So if you have your own journey, Hale, which might be different than mine, your experience can be different than mine. We have to have that spectrum, that ability to personalize. So in the past, that personalization came through curation, right? So as a distributor, if you were my customer, I would create a program for you based on the SKUs that we had available and the activities that I wanted to add to those SKUs to help you achieve your goal. We don't want to lose that. That's our core.
That's not going away. It's how do we bolt onto that to improve that experience? The product lines that you just spoke about, they don't cannibalize that model. They add to that model. That's important because we're delivering great results right now. We have volume growth. We have net sales growth. How do we build on top of that? How do we increase that customer journey to make it more personalized? We can do that through, first Pro2col, you mentioned Pro2col. Pro2col is an experience layer. It's an app for the distributor and the customer, excuse me, the distributor and the company to get more consumer data. The more consumer data you have, the greater the ability to personalize. If that data is in our technology ecosystem, we can create scalability for a distributor, then personalize, so they don't have to do all the work.
AI, the computer system, technology can help with that personalization. That's the data side. The other products you mentioned are more personalized formulation. With Link BioSciences, right now we were able to create 40 different unique formulas for— It's vitamin and mineral supplementation. Most of our products right now are food. When you think of Bionic, think of an incremental product line that we don't sell a lot of today in supplements. It gets us in the supplement business. Within those 40 formulas, we can take your needs and say, "This formula is best for you." That's an increased level of personalization. When you get to Link BioSciences, which we haven't launched yet, we bought that. That actually can do a greater level of personalization. It doesn't have to be 40 SKUs. It can be one SKU just for you because it has those capabilities.
Every one of these products you just mentioned fit in the journey for the consumer in a different way as we move from personally curated all the way up to personally formulated.
Okay. Pro2col's been in beta for a little bit now. Maybe you could talk about the user experience and the ability to do the blood testing on it because that adds some complexity in terms of the whole model, what you've learned from the guys that are in beta, and what makes you excited about it.
Yeah. So again, Pro2col is the user experience. We purchased that. It was a concept that was in development that we purchased that is in beta so that we can learn. I am going to separate that from blood tests because blood tests are not critical to Pro2col working. Blood tests can work within Pro2col. Blood tests can give us biomarkers that help us personalize, but it is not necessary, although we did launch beta of blood tests because that is ultimately where the market is going to go. We do not necessarily need to be in the blood testing business. It is a commodity now. We just need the ability for consumers that want to use that data to be able to use it within Pro2col so that that information can be used ultimately to create personalized nutrition. So I am going to put that one aside.
What we have learned in Pro2col is, again, I am going to repeat what I said earlier. For the application to be successful, two things have to happen. It has to add value to the consumer and help distributors sell more product to make money, right? Our distributors go to market in many different ways, and it has to fit those methods. So what we have learned is what are the needs that a consumer has, and we have to work those needs into the app, and how does the distributor ultimately generate revenue from it? I do not mean application revenue, I mean sell more product. That is the process we are in now with these labs. We call them labs. There is a concept we call DMO, Daily Method of Operations, the business flows of each distributors.
Those labs are happening now to know what the actual needs are for the distributor to have successful Pro2col.
Yeah. If I could just add to that, too, I think that part of the learning has been not having to own the first mile, so things like the blood test and doing our own and creating our own. Obviously, we want to take the input side of it, but we do not need to own the actual input aspect of it. It is more important for us to own the last mile. What does that actually create? How can we leverage that to use? Can we get product recommendations out of it for distributors to help them help their business? So owning the last mile, I think, has been a good part of the journey.
When we think about personalization and what that does for metrics, or from my world on the Excel spreadsheet, is it customer acquisition? Is it retention? Is it basket size? Is it gross margin? Or should I just be thinking about it as just, it helps distributors sell more, which helps get distributors excited to retain distributors or grow your base, which then sells more?
I break it into two buckets, and then we can break it further, right? There is direct impact and indirect impact. Direct impact is the ability to sell more personalization. The indirect impact is the energy and excitement distributors feel around that personalization will also help them sell more core product because it helps activation.
Yeah.
Activation is a more customers can come in. Second, you want to increase the economic value of those customers. A distributor's single most constraining asset is their time. They are very small businesses. Technology, through Pro2col, through personalization, can create a technology connection to the consumer that will help the distributor scale their business better.
We have two minutes left, and I got two questions.
Okay.
You are going to have to be tight.
All right.
The first one is on India. Can you guys give us sort of a state of the state? What happens next month, what people should be paying attention to?
Yeah. India, it is becoming our largest market. September of last year, right at the end of it, India lowered the goods side of the GST, which is effectively a sales tax, from 18%- 5%. Leading into that change, India, for us, had 18 years of consecutive growth, and basically that change that made the price lower for the consumer at the time of purchase accelerated that business. The 13% decrease actually yielded over 40% increase in volume growth for us. So pretty significant movement in a market that was already having great growth. What has happened since that window, and since we are getting towards the anniversary of it at the end of this month is not just increase in purchase activity, but actually a lot of people that have come into the business opportunity side of it. Because they have a great flow.
They bring people in as preferred customers. They have a membership model, as well as Nutrition Clubs that they go through. Basically, the way that their flow works is they have brought in significantly new preferred customers, the actual people that have come in for the business opportunity side. Then from there, sales leaders, if you think of our business, it is a funnel, right? New people coming into the system, new distributors, right? They are actually not producing a significant amount of volume because they are learning the business. Then at the bottom of the funnel is our sales leaders. These are our storefronts. These are people that have been in the business. They are starting to qualify for production bonus levels, and that has now started to grow in double digits. The actual inputs of the business as we lap this have become pretty strong.
We believe that this momentum is going to continue past the anniversary in September.
My last one, John, is like, as you guys know, I am a credit analyst, so I do not make stock picks at all. Maybe you guys want to make a pitch on why Herbalife is good stock right now.
Well, tremendously undervalued. I mean, our EBITDA multiple has been hovering between four and five. For a company that is growing volume, growing net sales, has 23% free cash flow yield, has historically generated free cash every year since I have been here in 18 years. We now have a buyback program. First of all, the business is generating a lot of cash, undervalued. Second is we are using that cash, we have been using it to pay down debt, which transfers value from debt holders to equity holders. Now we are looking for an incremental way to create value for equity holders through buyback. So you got a business performing well, generating a lot of cash, using that cash to pay down debt and buy back stock. I mean, I personally think it is a big opportunity.
Even if you just look at our free cash flow yield and we just keep buying back stock or paying down debt, and that just increases the equity value. That alone has a big opportunity for us.
All right. Thank you, guys.
Thank you.
Thank you.